Stock PEN PENUMBRA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Penumbra, Inc.

Equities

PEN

US70975L1070

Real-time Estimate Cboe BZX
Other stock markets
 12:27:20 2024-07-10 pm EDT 		5-day change 1st Jan Change
178.4 USD +0.20% Intraday chart for Penumbra, Inc. +0.54% -29.09%
Jun. 18 Transcript : Penumbra, Inc. Presents at 2024 Truist Securities MedTech Conference, Jun-18-2024 10:00 AM
Jun. 06 Transcript : Penumbra, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-06-2024 11:20 AM

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
PR
Transcript : Penumbra, Inc. Presents at 2024 Truist Securities MedTech Conference, Jun-18-2024 10:00 AM
Transcript : Penumbra, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-06-2024 11:20 AM
Penumbra, Inc. to Present at the Truist Securities MedTech Conference
PR
Penumbra, Inc. to Present at the William Blair Growth Stock Conference
PR
Penumbra Insider Sold Shares Worth $3,014,734, According to a Recent SEC Filing
MT
Transcript : Penumbra, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-15-2024 08:00 AM
Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating
MT
Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook
MT
Penumbra: Q1 Earnings Snapshot
AQ
Transcript : Penumbra, Inc., Q1 2024 Earnings Call, May 07, 2024
Earnings Flash (PEN) PENUMBRA Reports Q1 Revenue $278.7M, vs. Street Est of $274.5M
MT
Earnings Flash (PEN) PENUMBRA Reports Q1 EPS $0.41, vs. Street Est of $0.38
MT
Penumbra, Inc. Reports First Quarter 2024 Financial Results
PR
Penumbra, Inc. Reiterates Earnings Guidance for the Year 2024
CI
Penumbra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
PR
Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
PR
Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
CI
DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PEN Stock
  4. News Penumbra, Inc.